Blogs

Intrabio research update – October 2018

We are pleased to share the below from Intrabio and their research into a potential treatment for Tay-Sachs and Sandhoff disease. IntraBio Inc is pleased to announce that the US Food and Drug Administration has granted a Rare Pediatric Disease Designation for their lead compound series, IB1000s, for the treatment of GM2 Gangliosidoses (Tay-Sachs and…

READ MORE
Blogs

Intrabio research update – August 2018

We are pleased to share the below from Intrabio and their research into a potential treatment for Tay-Sachs and Sandhoff disease. I am pleased to share highlights of the significant progress IntraBio Inc. has made during 2018. These regulatory, clinical, and corporate accomplishments have prepared us for planned, multinational clinical studies with N-Acetyl-L-Leucine for Niemann-Pick…

READ MORE
Blogs

IntraBio research update – January 2018

We are pleased to share the below from Intrabio and their research into a potential treatment for Tay-Sachs and Sandhoff disease. Below, I am pleased to share highlights of the significant progress we have made over the last quarter of 2017, which have prepared IntraBio to conduct multi-national (EU and US), placebo-controlled, clinical trials in…

READ MORE
Blogs

mtn-i MTN Showcase & Awards 2017

We want to say a big thank you to mtn-i for once again choosing to support The CATS Foundation during their MTN Showcase & Awards!  We had a brilliant night at the event where the charity was invited to share the most recent work the charity has been doing. This year, £6, 000 was raised and it was split between The…

READ MORE
Blogs

Stanley’s story

Stanley Murphy is two years old and has Tay Sachs. He has no muscle tone and cannot move or support his head. He often has seizures and may not live to three year’s old. His rare condition means he cannot move and must lie horizontally, yet his mum and dad have been told he must be…

READ MORE